Yürekli Yakup, Unak Perihan, Yenisey Ciğdem, Ertay Türkan, Biber Müftüler Fazilet Zumrut, Medine Emin İlker
Adnan Menderes University, Department of Nuclear Medicine, School of Medicine, Aydin, Turkey.
Mol Imaging Radionucl Ther. 2011 Apr;20(1):1-6. doi: 10.4274/MIRT.20.01. Epub 2011 Apr 1.
In this study, we aimed to investigate the cytoprotective effect of L-carnitine against cisplatin-induced nephrotoxicity and to compare its efficacy with that of amifostin by quantitative renal Tc 99m DMSA uptake.
Male Wistar rats were randomly divided into six groups of six animals each. 1) Control (saline; 5 ml/kg intraperitoneally); 2) L-carnitine (CAR; 300 mg/kg intraperitoneally); 3) Amifostine (AMI; 200 mg /kg intraperitoneally); 4) Cisplatin (CIS;7 mg/kg intraperitoneally); 5) Cisplatin plus L-carnitine (CIS + CAR); 6) Cisplatin plus amifostine (CIS + AMI). L-carnitine and amifostine were injected 30 minutes before cisplatin in Group 5 and 6. Tc 99m DMSA, 7.4 MBq/0.2 ml, was injected through the tail vein 72 hours after the drug administration. Rats were killed and kidneys removed by dissection 2 hours after the injection of the radiopharmaceutical. The percentage of the injected dose per gram of kidney tissue (%ID/g) was calculated. Renal function was monitored by measuring BUN and plasma levels of creatinine. Lipid peroxidation and glutathione content were determined by measuring malondialdehyde (MDA) and reduced glutathione (GSH) in kidney tissue homogenates.
Tc 99m DMSA uptake per gram tissue of the kidney as %ID/g was 29.54±4.72, 29.86 ± 7.47 and 26.37 ± 4.54 in the control, CAR and AMI groups respectively. %ID/g was the lowest of all the groups, 11.60±3.59 (p<0.01), in the cisplatin group. Carnitine or amifostine administration 30 minutes before cisplatin injection resulted a significant increase in %ID/g, 21.28±7.73 and 18.97±3.24 respectively, compared to those of cisplatin-treated rats (p<0.002). A marked increase in plasma BUN and creatinine indicating nephrotoxicity and acute renal failure was observed in the cisplatin-treated group. MDA and GSH levels were concordant with cisplatin-induced oxidative stress in the kidney tissue.
The results showed that L-carnitine significantly attenuates the cisplatin-induced nephrotoxicity as amifostin.
None declared.
在本研究中,我们旨在研究左旋肉碱对顺铂诱导的肾毒性的细胞保护作用,并通过定量肾脏锝99m二巯基丁二酸(Tc 99m DMSA)摄取来比较其与氨磷汀的疗效。
雄性Wistar大鼠随机分为六组,每组六只动物。1)对照组(生理盐水;5 ml/kg腹腔注射);2)左旋肉碱组(CAR;300 mg/kg腹腔注射);3)氨磷汀组(AMI;200 mg /kg腹腔注射);4)顺铂组(CIS;7 mg/kg腹腔注射);5)顺铂加左旋肉碱组(CIS + CAR);6)顺铂加氨磷汀组(CIS + AMI)。在第5组和第6组中,左旋肉碱和氨磷汀在顺铂注射前30分钟注射。给药72小时后,通过尾静脉注射7.4 MBq/0.2 ml的Tc 99m DMSA。注射放射性药物2小时后,处死大鼠并解剖取出肾脏。计算每克肾脏组织中注射剂量的百分比(%ID/g)。通过测量血尿素氮(BUN)和血浆肌酐水平监测肾功能。通过测量肾脏组织匀浆中的丙二醛(MDA)和还原型谷胱甘肽(GSH)来测定脂质过氧化和谷胱甘肽含量。
对照组、CAR组和AMI组每克肾脏组织的Tc 99m DMSA摄取量(%ID/g)分别为29.54±4.72、29.86 ± 7.47和26.37 ± 4.54。顺铂组的%ID/g在所有组中最低,为11.60±3.59(p<0.01)。在顺铂注射前30分钟给予肉碱或氨磷汀,与顺铂治疗的大鼠相比,%ID/g显著增加,分别为21.28±7.73和18.97±3.24(p<0.002)。在顺铂治疗组中观察到血浆BUN和肌酐显著升高,表明存在肾毒性和急性肾衰竭。MDA和GSH水平与顺铂诱导的肾脏组织氧化应激一致。
结果表明,左旋肉碱与氨磷汀一样,能显著减轻顺铂诱导的肾毒性。
未声明。